Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC
Clinical trial NCT00452881 · UNKNOWN
Trial details
- NCT number
- NCT00452881
- Sponsor
- National Cancer Center, Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.